In a study of 449 patients with severe COVID-19 and sepsis-induced coagulopathy criteria or with markedly elevated D-dimer levels (higher than sixfold of upper limit of normal), anticoagulant therapy, mainly with low-molecular-weight heparin, was associated with better prognosis [34].